Abstract
Manganese dioxide (MnO2) are attractive for biomedical applications due to their biocompatibility, stimuli-responsive magnetic resonance imaging (MRI) properties and capability to modulate the hypoxic tumour microenvironment (TME).
Funding Information
  • National Key Research and Development Program of China (2018YFA0903500)
  • China Postdoctoral Science Foundation (2018M630849)
  • Fundamental Research Funds for the Central Universities (2172019kfyXMPY006, 2172020kfyXGYJ104)

This publication has 54 references indexed in Scilit: